In addition, patients presenting with SFI had higher comorbidity burden, more often had directly been transferred to CR from acute care hospitals after a hospitalization for HF—that is, when the risk of adverse clinical events is highest, had higher NT-proBNP levels, and had poorer prognosis, thus representing a highly challenging population in the CR setting. This evidence concerns the gene NPPB and hydrops fetalis.